Jefferies Financial Group Inc. Sells 4,388 Shares of Colgate-Palmolive Company (NYSE:CL)

Jefferies Financial Group Inc. decreased its holdings in Colgate-Palmolive Company (NYSE:CL) by 29.9% during the 1st quarter, HoldingsChannel reports. The firm owned 10,279 shares of the company’s stock after selling 4,388 shares during the quarter. Jefferies Financial Group Inc.’s holdings in Colgate-Palmolive were worth $963,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also modified their holdings of CL. Cornerstone Wealth Management LLC boosted its position in Colgate-Palmolive by 1.2% in the first quarter. Cornerstone Wealth Management LLC now owns 9,035 shares of the company’s stock valued at $847,000 after buying an additional 110 shares in the last quarter. Aberdeen Wealth Management LLC boosted its stake in shares of Colgate-Palmolive by 0.6% during the fourth quarter. Aberdeen Wealth Management LLC now owns 20,651 shares of the company’s stock valued at $1,877,000 after purchasing an additional 125 shares in the last quarter. Town & Country Bank & Trust CO dba First Bankers Trust CO grew its holdings in shares of Colgate-Palmolive by 4.0% during the first quarter. Town & Country Bank & Trust CO dba First Bankers Trust CO now owns 3,388 shares of the company’s stock worth $317,000 after purchasing an additional 130 shares during the last quarter. Continuum Advisory LLC boosted its position in Colgate-Palmolive by 17.2% during the 4th quarter. Continuum Advisory LLC now owns 893 shares of the company’s stock worth $81,000 after buying an additional 131 shares during the period. Finally, KFG Wealth Management LLC grew its holdings in Colgate-Palmolive by 1.5% during the 1st quarter. KFG Wealth Management LLC now owns 8,835 shares of the company’s stock worth $828,000 after acquiring an additional 131 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors.

Colgate-Palmolive Stock Down 0.2%

CL stock opened at $83.33 on Tuesday. The company has a debt-to-equity ratio of 8.96, a current ratio of 0.43 and a quick ratio of 0.28. Colgate-Palmolive Company has a 1-year low of $82.40 and a 1-year high of $109.30. The stock has a market capitalization of $67.53 billion, a P/E ratio of 23.41, a P/E/G ratio of 4.31 and a beta of 0.35. The business has a fifty day moving average price of $89.40 and a 200-day moving average price of $90.27.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, August 1st. The company reported $0.92 EPS for the quarter, topping the consensus estimate of $0.89 by $0.03. The company had revenue of $5.11 billion during the quarter, compared to analyst estimates of $5.03 billion. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%. Colgate-Palmolive’s revenue was up 1.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.91 earnings per share. Equities analysts forecast that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 15th. Stockholders of record on Friday, July 18th will be paid a $0.52 dividend. The ex-dividend date of this dividend is Friday, July 18th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.5%. Colgate-Palmolive’s dividend payout ratio is 58.43%.

Analysts Set New Price Targets

Several analysts recently weighed in on the stock. Citigroup reduced their price objective on shares of Colgate-Palmolive from $108.00 to $105.00 and set a “buy” rating on the stock in a research note on Monday. UBS Group lowered their price target on shares of Colgate-Palmolive from $109.00 to $106.00 and set a “buy” rating for the company in a report on Thursday, July 17th. Morgan Stanley decreased their price objective on shares of Colgate-Palmolive from $104.00 to $96.00 and set an “overweight” rating for the company in a research report on Monday. JPMorgan Chase & Co. dropped their target price on shares of Colgate-Palmolive from $99.00 to $95.00 and set an “overweight” rating on the stock in a report on Monday. Finally, Wall Street Zen lowered Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Wednesday, May 7th. One analyst has rated the stock with a sell rating, five have issued a hold rating and seven have assigned a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $98.92.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.